Jasper Therapeutics (JSPR) awards 7,500 stock options to board director
Rhea-AI Filing Summary
Jasper Therapeutics director Lucas Svetlana received an automatic grant of stock options covering 7,500 shares of Voting Common Stock. The options were awarded under the Non-Employee Director Compensation Policy at an exercise price of $0.6300 per share, vesting in full on the first anniversary of the grant, and leave Lucas holding 7,500 derivative securities.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Lucas Svetlana
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy F1 | 7,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy — 7,500 shares (Direct)
Footnotes (1)
- F1. Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.
Key Figures
Stock options granted: 7,500 shares
Exercise price: $0.6300 per share
Expiration date: 2036-07-31
+2 more
5 metrics
Stock options granted
7,500 shares
Stock Option (Right to Buy) awarded to director on 2026-07-31
Exercise price
$0.6300 per share
Conversion or exercise price of the granted stock options
Expiration date
2036-07-31
Expiration date of the stock option grant
Underlying Voting Common Stock
7,500 shares
Number of Voting Common Stock shares underlying the option
Derivative holdings after grant
7,500 options
Total derivative securities held following this award
Key Terms
Non-Employee Director Compensation Policy, Stock Option (Right to Buy, vesting, exercise price
4 terms
Non-Employee Director Compensation Policy financial
"Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy"
Stock Option (Right to Buy financial
"security_title: Stock Option (Right to Buy"
vesting financial
"which shall vest in full upon the first anniversary of the date of the grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: 0.6300"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did JSPR report for Lucas Svetlana?
Jasper Therapeutics reported that director Lucas Svetlana received a grant of 7,500 stock options. The options are for Voting Common Stock, were granted as director compensation, and increase Lucas’s derivative holdings to 7,500 options following the transaction.
What is the exercise price of the stock options granted by JSPR?
The granted options have an exercise price of $0.6300 per share. This is the price at which Lucas Svetlana may purchase Jasper Therapeutics Voting Common Stock upon exercising the 7,500 stock options after they vest.
When do Lucas Svetlana’s JSPR director options vest?
The options granted to Lucas Svetlana vest in full on the first anniversary of the grant date. Vesting is conditioned on continued service as a director through that anniversary under the Non-Employee Director Compensation Policy.
Under what policy were the JSPR stock options granted to Lucas Svetlana?
The options were granted automatically under Jasper Therapeutics’ Non-Employee Director Compensation Policy. This policy provides that non-employee directors receive an option to purchase 7,500 shares on each annual stockholder meeting date, with full vesting after one year of service.
What are Lucas Svetlana’s Jasper Therapeutics derivative holdings after this Form 4?
Following the reported transaction, Lucas Svetlana holds 7,500 derivative securities in the form of stock options. These options relate to 7,500 shares of Voting Common Stock and reflect the entire derivative position shown in this report.